Exploring the psychological effects of GTN treatment on women
The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment
This study is trying to understand how women feel emotionally after finishing treatment for Gestational Trophoblastic Neoplasia and what kind of support they have received.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 16 Years to 55 Years |
| Sex | Female |
| Sponsor | Sheffield Teaching Hospitals NHS Foundation Trust Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Sheffield, South Yorkshire) |
| Trial ID | NCT06169644 on ClinicalTrials.gov |
What this trial studies
This observational study aims to understand the psychological impact of Gestational Trophoblastic Neoplasia (GTN) on women who have completed chemotherapy treatment. It involves conducting semi-structured telephone interviews with a sample of 20 women, who are between 6 weeks and 24 months post-treatment. The study seeks to gain insights into their emotional experiences, assess the adequacy of psychological support provided by health professionals, and identify sources of support accessed by patients after treatment. Thematic analysis will be employed to analyze the interview data and provide a comprehensive understanding of the patients' experiences.
Who should consider this trial
Good fit: Ideal candidates are women who have been treated with chemotherapy for GTN and completed their treatment between 6 weeks and 24 months ago.
Not a fit: Patients who received treatment less than 6 weeks ago or more than 24 months ago, as well as non-English speakers, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance psychological support for women recovering from GTN, leading to improved mental health outcomes.
How similar studies have performed: While there is limited research specifically on the psychological impact of GTN, similar studies on cancer survivors have shown the importance of addressing psychological support needs.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Treated with chemotherapy for a GTN diagnosis * Completed treatment between 6 weeks and 24 months * Are able to provide informed consent * Have no cognitive impairment as judged by the treating clinician Exclusion Criteria: * Treatment received less than 6 weeks ago * Treatment received more than 24 months ago * Non-English speaking
Where this trial is running
Sheffield, South Yorkshire
- Weston Park Hospital — Sheffield, South Yorkshire, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Kamaljit Singh — Nurse Consultant
- Study coordinator: Kamaljit Singh
- Email: kamaljitsingh@nhs.net
- Phone: 01142265274
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.